Yasuo Imanishi

Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia

Kenneth B. Jonsson, R Zahradnik, Tobias E. Larsson et al. · New England Journal of Medicine · 2003 · 907 citations · Full text

Glycated Albumin Is a Better Glycemic Indicator than Glycated Hemoglobin Values in Hemodialysis Patients with Diabetes

Masaaki Inaba, Senji Okuno, Yasuro Kumeda et al. · Journal of the American Society of Nephrology · 2007 · 485 citations

Better Glycemic Indicator, Hemodialysis Patients, Metabolic Syndrome +17

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis

Karl Insogna, Karine Briot, Erik A. Imel et al. · Journal of Bone and Mineral Research · 2018 · 329 citations · Full text

Sclerostin, Human Growth, Immunology +21

Presence of Abdominal Aortic Calcification Is Significantly Associated With All-Cause and Cardiovascular Mortality in Maintenance Hemodialysis Patients

Senji Okuno, Eiji Ishimura, Kayoko Kitatani et al. · American Journal of Kidney Diseases · 2007 · 275 citations

Abdominal Aortic Calcification, Hemodialysis, Urology +10

FGF-23 in patients with end-stage renal disease on hemodialysis

Yasuo Imanishi, Masaaki Inaba, Kiyoshi Nakatsuka et al. · Kidney International · 2004 · 272 citations

Glomerulonephritis, Hemodialysis, Urology +8